By: Statement | January 29, 2015
“AdvaMed would like to commend Sens. Alexander and Burr for their leadership on this important issue. We share their goal of improving the efficiency and predictability of processes at both NIH and FDA to ensure patients have timely access to the latest medical advancements."
By: Statement | January 28, 2015
“AdvaMed welcomes reforms that India is pursuing to make it easier to do business in India, including a recent change in Foreign Direct Investment policy that clears the way for greater foreign participation and investment in India’s medical device market, and we are encouraged by continuing efforts to create an appropriate regulatory framework for devices distinct from pharmaceuticals. "
By: Press Release | January 28, 2015
“The reduction in R&D is especially troubling as investments in research today are the cures and treatments of tomorrow. The effects of this tax could have a damaging ripple effect for decades to come if left unaddressed. This tax is not just a tax on medical technology companies. It’s a tax on medical progress. "